Sigma Healthcare Limited has outlined its governance practices and ESG initiatives, focusing on climate-related financial disclosures and waste diversion efforts. The company’s chairman, Michael Sammells, highlighted the importance of strong governance in delivering the company’s strategy and noted the effectiveness of the Related Party Independent Board Committee (IBC) in overseeing related-party transactions.
Material Actions and Disclosures
The company’s FY26 marked its first mandatory climate-related financial disclosures under AASB S2. The Board retains overall accountability for sustainability strategy and climate-related risks and opportunities, supported by the Risk, Compliance and Sustainability Committee and the Audit Committee. Climate risks are considered within the enterprise risk management framework and inform strategy and decision-making.
During FY26, Sigma’s Australian operations diverted 5,570 tonnes of waste from landfill, representing over 80% of the waste generated. The company maintained its commitment to the Australian Packaging Covenant and invested over $7.5 million in supporting communities across Australia and New Zealand.
Health and safety measures form part of executive performance assessment, alongside core operational delivery and merger synergies, reinforcing the connection between performance and the care for employees.
Forward Commitments
According to the announcement, Sigma expects the proportion of related-party transactions to decline over time as the network grows, aligning with the company’s strategic goal of expanding its network to 900 Chemist Warehouse stores across Australia.